244 related articles for article (PubMed ID: 12458911)
41. The need for developmental neurotoxicity studies in risk assessment for developmental toxicity.
Hass U
Reprod Toxicol; 2006 Aug; 22(2):148-56. PubMed ID: 16777374
[TBL] [Abstract][Full Text] [Related]
42. Potential future requirements for immunotoxicology testing of pesticides.
Sjoblad RD
Toxicol Ind Health; 1988 Sep; 4(3):391-5. PubMed ID: 3176044
[TBL] [Abstract][Full Text] [Related]
43. Species comparison of anatomical and functional immune system development.
Holsapple MP; West LJ; Landreth KS
Birth Defects Res B Dev Reprod Toxicol; 2003 Aug; 68(4):321-34. PubMed ID: 14666995
[TBL] [Abstract][Full Text] [Related]
44. Workshop report. Children as a special subpopulation: focus on immunotoxicity. Federal Institute for Health Protection of Consumers and Veterinary Medicine (BgVV), 15-16 November 2001, Berlin, Germany.
Richter-Reichhelm HB; Althoff J; Schulte A; Ewe S; Gundert-Remy U
Arch Toxicol; 2002 Jul; 76(7):377-82. PubMed ID: 12222155
[TBL] [Abstract][Full Text] [Related]
45. Developmental immunotoxicity of atrazine in rodents.
Rowe AM; Brundage KM; Barnett JB
Basic Clin Pharmacol Toxicol; 2008 Feb; 102(2):139-45. PubMed ID: 18226067
[TBL] [Abstract][Full Text] [Related]
46. Gender-based differences in endocrine and reproductive toxicity.
Cummings AM; Stoker T; Kavlock RJ
Environ Res; 2007 May; 104(1):96-107. PubMed ID: 17157289
[TBL] [Abstract][Full Text] [Related]
47. Juvenile toxicity testing protocols for chemicals.
Piersma AH; Tonk EC; Makris SL; Crofton KM; Dietert RR; van Loveren H
Reprod Toxicol; 2012 Nov; 34(3):482-6. PubMed ID: 22564981
[TBL] [Abstract][Full Text] [Related]
48. Potential for early-life immune insult including developmental immunotoxicity in autism and autism spectrum disorders: focus on critical windows of immune vulnerability.
Dietert RR; Dietert JM
J Toxicol Environ Health B Crit Rev; 2008 Oct; 11(8):660-80. PubMed ID: 18821424
[TBL] [Abstract][Full Text] [Related]
49. Significance of excursions of intake above the acceptable daily intake: effect of time and dose in developmental toxicology.
Sullivan FM
Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S94-8. PubMed ID: 10597620
[TBL] [Abstract][Full Text] [Related]
50. Developmental immunotoxicology of lead.
Dietert RR; Lee JE; Hussain I; Piepenbrink M
Toxicol Appl Pharmacol; 2004 Jul; 198(2):86-94. PubMed ID: 15236947
[TBL] [Abstract][Full Text] [Related]
51. Juvenile immunotoxicology.
Holsapple MP; O'Lone R
Toxicol Pathol; 2012; 40(2):248-54. PubMed ID: 22252913
[TBL] [Abstract][Full Text] [Related]
52. The effects of feed restriction during in utero and postnatal development in rats.
Carney EW; Zablotny CL; Marty MS; Crissman JW; Anderson P; Woolhiser M; Holsapple M
Toxicol Sci; 2004 Nov; 82(1):237-49. PubMed ID: 15310860
[TBL] [Abstract][Full Text] [Related]
53. Summary of a workshop on nonclinical and clinical immunotoxicity assessment of immunomodulatory drugs.
Piccotti JR; Lebrec HN; Evans E; Herzyk DJ; Hastings KL; Burns-Naas LA; Gourley IS; Wierda D; Kawabata TT
J Immunotoxicol; 2009 Mar; 6(1):1-10. PubMed ID: 19519157
[TBL] [Abstract][Full Text] [Related]
54. Investigative Immunotoxicology.
Anderson SE; Shane HL
Methods Mol Biol; 2018; 1803():27-46. PubMed ID: 29882131
[TBL] [Abstract][Full Text] [Related]
55. Defining critical windows in the development of the human immune system.
West LJ
Hum Exp Toxicol; 2002; 21(9-10):499-505. PubMed ID: 12458907
[TBL] [Abstract][Full Text] [Related]
56. Consensus workshop on methods to evaluate developmental immunotoxicity.
Luster MI; Dean JH; Germolec DR
Environ Health Perspect; 2003 Apr; 111(4):579-83. PubMed ID: 12676619
[TBL] [Abstract][Full Text] [Related]
57. [Alternative methods to animal experiments. What can they afford in the safety testing of chemical substances under REACH?].
Lilienblum W
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1434-43. PubMed ID: 19137219
[TBL] [Abstract][Full Text] [Related]
58. REACH and reproductive and developmental toxicology: still questions.
Scialli AR; Guikema AJ
Syst Biol Reprod Med; 2012 Feb; 58(1):63-9. PubMed ID: 22239083
[TBL] [Abstract][Full Text] [Related]
59. Developmental immunotoxicity (DIT) in drug safety testing: matching DIT testing to adverse outcomes and childhood disease risk.
Dietert RR
Curr Drug Saf; 2008 Sep; 3(3):216-26. PubMed ID: 18691005
[TBL] [Abstract][Full Text] [Related]
60. Immunotoxicant screening and prioritization in the twenty-first century.
Luebke R
Toxicol Pathol; 2012; 40(2):294-9. PubMed ID: 22105646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
